SARA SPEAKER: Open Payments
NPI 1700599081 · RICHMOND, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,714 in 99 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $751 · 2025 $1,714
Food & beverage: $1,637Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $226 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $202 |
| Lilly USA, LLC | 9 | $167 |
| PFIZER INC. | 10 | $143 |
| Dexcom, Inc. | 5 | $121 |
| Otsuka America Pharmaceutical, Inc. | 5 | $110 |
| Astellas Pharma US Inc | 3 | $110 |
| AstraZeneca Pharmaceuticals LP | 5 | $86 |
| Teva Pharmaceuticals USA, Inc. | 5 | $84 |
| Novartis Pharmaceuticals Corporation | 4 | $78 |
Products named: CAPLYTA, VRAYLAR, Dexcom G6 Transmitter, REXULTI, MOUNJARO, JARDIANCE, AUSTEDO XR, LEQVIO.
Industry payments across MO — which companies pay providers there.
